← Back to Search

LeoMed Telecare Platform for Outpatient Surgery Optimization (MEET-OS Trial)

N/A

Waitlist Available

Led By Florian Robin, MD, FRCPC

Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients over 18 years old undergoing elective outpatient surgery under general or regional anesthesia

Written, oral and spoken comprehension of French or English

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 month after the surgery

Awards & highlights

MEET-OS Trial Summary

This trial will compare a new surgical platform to the current standard of care in order to evaluate its effectiveness and cost.

Who is the study for?

This trial is for adults over 18 who are having elective outpatient surgery under general or regional anesthesia. They must have internet access at home and understand French or English. It's not for those who can't use digital tech, if the surgery changes to inpatient on the day, or if the patient refuses.Check my eligibility

What is being tested?

The study evaluates a new telecare platform called LeoMed for patients after outpatient surgery. Participants will either use the complete LeoMed application or a basic version to see how it affects their recovery and satisfaction compared to standard care.See study design

What are the potential side effects?

Since this trial involves using an application rather than medication, traditional side effects aren't expected. However, there may be issues related to usability of the app or discomfort with technology that could affect patient satisfaction.

MEET-OS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am over 18 and scheduled for surgery with anesthesia.

Select...

I can understand and communicate in either French or English.

MEET-OS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 month after the surgery

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 month after the surgery

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month after the surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Cost-effectiveness analysis of the LeoMed® telecare platform

Secondary outcome measures

Cost-utility analysis of the LeoMed® telecare platform

Patient satisfaction

MEET-OS Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Complete LeoMed applicationActive Control1 Intervention

LeoMed application with integrated artificial intelligence

Group II: Basic LeoMed applicationPlacebo Group1 Intervention

LeoMed application without artificial intelligence

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor

366 Previous Clinical Trials

128,637 Total Patients Enrolled

HEC MontrealUNKNOWN

1 Previous Clinical Trials

54 Total Patients Enrolled

Florian Robin, MD, FRCPCPrincipal InvestigatorCentre hospitalier de l'Université de Montréal (CHUM)

1 Previous Clinical Trials

54 Total Patients Enrolled

Media Library

Complete LeoMed application Clinical Trial Eligibility Overview. Trial Name: NCT04948632 — N/A

Patient Satisfaction Research Study Groups: Complete LeoMed application, Basic LeoMed application

Patient Satisfaction Clinical Trial 2023: Complete LeoMed application Highlights & Side Effects. Trial Name: NCT04948632 — N/A

Complete LeoMed application 2023 Treatment Timeline for Medical Study. Trial Name: NCT04948632 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the main goals of this investigation?

"This medical trial, which will use a 1 month post-surgery timeline to assess outcomes, has two primary objectives: improving patient quality of life and measuring the cost efficiency of LeoMed® telecare. Secondary goals include assessing rate of unscheduled consultations, using EQ-5D-5L-VAS to gauge health states across five dimensions (mobility, self care, usual activities, pain/discomfort and anxiety/depression), as well as evaluating customer satisfaction with provided services."

Answered by AI

How many subjects are included in the investigation?

"Indeed, according to clinicaltrials.gov the trial has been open since January 21st 2022 and was last updated on October 11th 2022. The research is aiming to include 1000 participants from a single site."

Answered by AI

Is this clinical investigation still seeking participants?

"Indeed, the data hosted on clinicaltrials.gov verifies that this medical research is actively recruiting patients. The trial, which was first listed on January 21st 2022, requires 1000 volunteers from a single location and has been recently updated as of October 11th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Optimization of Outpatient Surgery at the CHUM Using the LeoMed Telecare Platform

2022. "Optimization of Outpatient Surgery at the CHUM Using the LeoMed Telecare Platform". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04948632.